[Treatment of 100 cases of essential atherogenic hyperlipoproteinemia].
D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010666:Phenylpropionates / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; D010666:Phenylpropionates; D002994:Clofibrate
A propos du traitement de 100 observations d'hyperlipoprotéinémies essentielles athérogènes